Testing how a heart ultrasound finding changes in sepsis treatment
Part of Infections clinical trials.
This study looks at how a measurement from a bedside heart ultrasound changes while treating people with sepsis or septic shock. It may help doctors understand how to monitor response to treatment using a quick ultrasound test.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be diagnosed with sepsis or septic shock
- You must be older than 17 years
- You would likely be able to do a bedside ultrasound exam (POCUS)
- You must not be currently in the emergency department
- You (or your legal representative) must be able to give consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses heart ultrasound (echocardiography) to help doctors decide how much fluid to give patients with sepsis, a serious blood infection. The goal is to improve how well the heart pumps and help patients recover better.
This study looks at how well the heart works with the blood vessels in people with sepsis or septic shock. It uses special ultrasound tests to measure heart function and may help find new ways to guide treatment.
This study tests whether a special ultrasound exam (VExUS) combined with a standard pressure measurement (CVP) can better predict outcomes for people with sepsis in the ICU. The goal is to see if these tools help doctors make better treatment decisions.
This trial is looking for patients who have an infection and are showing early signs of getting sicker, like a high warning score. It aims to find out if doctors can identify those at risk of sepsis sooner so they can start treatment earlier.
This study looks at how sepsis and other infections affect survival in hospitalized heart patients. It is designed for people who are being treated for a heart condition and either have no infection or have a specific type of infection or heart inflammation.
This trial tests a special way to monitor tiny blood vessels (microcirculation) in patients with sepsis. The goal is to see if early treatment based on these readings can help improve recovery.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.